Literature DB >> 2774056

Clonal rearrangements of immunoglobulin genes and progression to B cell lymphoma in cutaneous lymphoid hyperplasia.

G S Wood1, B Y Ngan, R Tung, T E Hoffman, E A Abel, R T Hoppe, R A Warnke, M L Cleary, J Sklar.   

Abstract

Cutaneous lymphoid hyperplasia (CLH) is a disorder characterized by the development of one or more skin lesions containing dense lymphoid infiltrates that exhibit the histopathologic features of a benign, reactive process. Nevertheless, some cases have been associated with the subsequent development of clinically overt lymphomas. This suggests that monoclonal populations may exist in some cases of CLH and that these cases may represent a subset more likely to evolve into lymphoma. To determine if such a subset of CLH can be distinguished, Southern blot analysis of DNA was used to study the immunogenotypic features of lesions from 14 patients with clinical, histopathologic, and immunopathologic findings characteristic of CLH. Five cases exhibited detectable clonal rearrangements of immunoglobulin genes. Furthermore, one of these five cases evolved into overt diffuse large cell lymphoma of B cell lineage during a 2-year follow-up of recurrent disease at the original cutaneous site. The immunoglobulin gene rearrangements of this lymphoma were identical to those of the prior CLH lesion. There was no evidence of detectable t(14;18) chromosomal translocations or clonal rearrangements of the beta gene of the T cell receptor in any case. It was concluded that CLH can be divided into two subsets based on the presence or absence of a clonal B cell population, and that overt lymphoma can arise from the former subset and contain the same B cell clone identified in the pre-existent CLH lesion.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2774056      PMCID: PMC1880232     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  31 in total

1.  Cutaneous lymphoid hyperplasia.

Authors:  W A Caro; H B Helwig
Journal:  Cancer       Date:  1969-09       Impact factor: 6.860

2.  The immunologic and clinicopathologic heterogeneity of cutaneous lymphomas other than mycosis fungoides.

Authors:  G S Wood; J S Burke; S Horning; R S Doggett; R Levy; R A Warnke
Journal:  Blood       Date:  1983-08       Impact factor: 22.113

Review 3.  Monoclonal gammopathy of undetermined significance (MGUS): a review.

Authors:  R A Kyle
Journal:  Clin Haematol       Date:  1982-02

4.  The immunologic phenotyping of bone marrow biopsies and aspirates: frozen section techniques.

Authors:  G S Wood; R A Warnke
Journal:  Blood       Date:  1982-05       Impact factor: 22.113

5.  Histopathological differentiation of benign and malignant cutaneous lymphocytic infiltrates.

Authors:  D M MacDonald
Journal:  Br J Dermatol       Date:  1982-12       Impact factor: 9.302

6.  Differential diagnosis of malignant and benign cutaneous lymphoid infiltrates: a study of 57 cases in which malignant lymphoma had been diagnosed or suspected in the skin.

Authors:  H L Evans; R K Winkelmann; P M Banks
Journal:  Cancer       Date:  1979-08       Impact factor: 6.860

7.  Lymphocytic infiltrates of the conjunctiva and orbit: immunohistochemical staining of 16 cases.

Authors:  R R Turner; P Egbert; R A Warnke
Journal:  Am J Clin Pathol       Date:  1984-04       Impact factor: 2.493

8.  The cell population of cutaneous B-cell lymphomas.

Authors:  R Willemze; C B de Graaff-Reitsma; W A van Vloten; C J Meijer
Journal:  Br J Dermatol       Date:  1983-04       Impact factor: 9.302

9.  Developmental hierarchy of immunoglobulin gene rearrangements in human leukemic pre-B-cells.

Authors:  S J Korsmeyer; P A Hieter; J V Ravetch; D G Poplack; T A Waldmann; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1981-11       Impact factor: 11.205

10.  The immunologic characterization of 40 extranodal lymphoid infiltrates: usefulness in distinguishing between benign pseudolymphoma and malignant lymphoma.

Authors:  D M Knowles; J P Halper; F A Jakobiec
Journal:  Cancer       Date:  1982-06-01       Impact factor: 6.860

View more
  4 in total

1.  Study of the reactive dendritic cells in small B-cell lymphoproliferations of the skin.

Authors:  Amélie Carbonnelle; Nadine Martin-Garcia; Nicolas Ortonne; Liliane Laroche; Martine Bagot; Valérie Molinier-Frenkel; Janine Wechsler
Journal:  Virchows Arch       Date:  2007-02-15       Impact factor: 4.064

2.  Radiation therapy for B-cell cutaneous lymphoid hyperplasia.

Authors:  Robert B Taylor; John A Fortney; Ross B Pollack; John S Metcalf; Joseph M Jenrette
Journal:  Jpn J Radiol       Date:  2010-06-30       Impact factor: 2.374

3.  Clonal B cell populations in a minority of patients with Hashimoto's thyroiditis.

Authors:  A Saxena; E C Alport; O Moshynska; R Kanthan; M A Boctor
Journal:  J Clin Pathol       Date:  2004-12       Impact factor: 3.411

Review 4.  Approach to Cutaneous Lymphoid Infiltrates: When to Consider Lymphoma?

Authors:  Yann Vincent Charli-Joseph; Michelle Gatica-Torres; Laura Beth Pincus
Journal:  Indian J Dermatol       Date:  2016 Jul-Aug       Impact factor: 1.494

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.